4.04
Design Therapeutics Inc Aktie (DSGN) Neueste Nachrichten
How high can Design Therapeutics Inc. stock price go in 2025Double or triple returns - jammulinksnews.com
What drives Design Therapeutics Inc. stock priceBreakthrough investment results - Autocar Professional
Design Therapeutics Inc. Stock Analysis and ForecastFree Stock Market Real-Time Monitoring - jammulinksnews.com
What analysts say about Design Therapeutics Inc. stockPhenomenal capital gains - jammulinksnews.com
Is Design Therapeutics Inc. a good long term investmentBreakthrough financial growth - jammulinksnews.com
Is ECASH(ethereumcash) a Good InvestmentLow Volatility High Yield Stocks - Newser
What drives AORT stock priceExceptional market positioning - PrintWeekIndia
Is Laureate Education Inc. a good long term investmentPhenomenal capital gains - Autocar Professional
Best Indian Stocks for Portfolio Protection AI Recommended Market StrategiesPhenomenal wealth increase - jammulinksnews.com
What analysts say about SBXC WS stockOutstanding capital appreciation - jammulinksnews.com
Is Design Therapeutics Inc. stock a growth or value playFree Membership Group - Newser
Design Therapeutics (NASDAQ:DSGN) Stock Price Down 3.1% – Should You Sell? - Defense World
Why Design Therapeutics Inc. stock attracts strong analyst attentionDefensive Stock Picks with Upside - beatles.ru
Why Synaptogenix Inc. stock attracts strong analyst attentionSecure Your Capital Strategy - Newser
What makes Design Therapeutics Inc. stock price move sharplyDaily Breakout Picks - Newser
How SIMAU stock performs during market volatilityFast Moving Stock Alerts - Newser
Why Sionna Therapeutics Inc. stock attracts strong analyst attentionFree VIP Investment Strategies - Newser
How Design Therapeutics Inc. stock performs during market volatilityElite Stock Shortlist - Newser
High-Potential Biotech Penny Stocks in 2025: ProKidney and Design Therapeutics Lead the Way - AInvest
Penny Stocks To Watch In July 2025 - simplywall.st
Maze Therapeutics Soars 11.68% on Wedbush's Outperform Rating - AInvest
BioVie Highlights Patient-Centric Design of SUNRISE-PD - GlobeNewswire
FDA Boosts CERo's Revolutionary T Cell Therapy with Orphan Drug Status for Deadly Blood Cancer - Stock Titan
PRDS(brise paradise) Future OutlookFree Group Entry - Newser
Design Therapeutics Confirms Directors at Annual Meeting - TipRanks
Design Therapeutics reports voting results from annual meeting - Investing.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):